Search results for "Skin Neoplasm"

showing 10 items of 283 documents

Mortality from cancer and other causes in commercial airline crews: a joint analysis of cohorts from 10 countries.

2014

Background Commercial airline crew is one of the occupational groups with the highest exposures to ionising radiation. Crew members are also exposed to other physical risk factors and subject to potential disruption of circadian rhythms. Methods This study analyses mortality in a pooled cohort of 93 771 crew members from 10 countries. The cohort was followed for a mean of 21.7 years (2.0 million person-years), during which 5508 deaths occurred. Results The overall mortality was strongly reduced in male cockpit (SMR 0.56) and female cabin crews (SMR 0.73). The mortality from radiation-related cancers was also reduced in male cockpit crew (SMR 0.73), but not in female or male cabin crews (SMR…

MaleNeoplasms Radiation-InducedSkin NeoplasmsAircrafthealth care facilities manpower and serviceseducationPopulationCrewBreast NeoplasmsJoint analysisCohort StudiesSex FactorsRisk FactorsCause of DeathNeoplasmsOccupational ExposureMedicineHumansOccupationseducationMelanomaCause of deatheducation.field_of_studyAcquired Immunodeficiency SyndromeLeukemiabusiness.industryBrain Neoplasmstechnology industry and agriculturePublic Health Environmental and Occupational HealthCancerMiddle Agedmedicine.diseaseUnited StatesCircadian RhythmEuropeOccupational DiseasesAccidents AviationCardiovascular DiseasesCohortFemaleSkin melanomabusinessCosmic RadiationCohort studyDemographyOccupational and environmental medicine
researchProduct

A significant percentage of CD20-positive TILs correlates with poor prognosis in patients with primary cutaneous malignant melanoma

2014

MaleOncologymedicine.medical_specialtyPoor prognosisSkin NeoplasmsHistologyMultivariate analysisMEDLINEPathology and Forensic MedicineText miningInternal medicinemedicineHumansIn patientMelanomaCD20biologybusiness.industryMelanomaDisease progressionGeneral MedicineAntigens CD20Prognosismedicine.diseaseMultivariate AnalysisDisease Progressionbiology.proteinFemalebusinessHistopathology
researchProduct

Updated review on prognostic factors in mycosis fungoides and new skin lymphoma trials

2021

BACKGROUND Ten-year survival rates in mycosis fungoides (MF) broadly varies, however, there is no standardized prognostic index available. This is presumably due to low prevalence, heterogeneity, and diagnostic challenges in MF. Recent studies have focused on identifying objective prognostic indices by using different parameters for survival determinants. The Cutaneous Lymphoma International Prognostic Index (CLIPI) and the Prospective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) represent prototypical studies that identify prognostic factors, seeking to improve management and outcomes in early-stage MF. Detecting these factors and stratifying MF patients according to their …

MaleOncologymedicine.medical_specialtySkin Neoplasms610 MedizinDermatologyDiseaseCutaneous lymphomaMycosis FungoidesInternational Prognostic IndexInternal medicine610 Medical sciencesmedicineHumansProspective StudiesStage (cooking)Neoplasm StagingMycosis fungoidesbusiness.industryLarge cellPrognosismedicine.diseaseLymphomaT-stageFemalebusiness
researchProduct

Phase 2 Trial of the Continuous IV Administration of Interferon-? in Patients With Disseminated Malignant Melanoma

2006

BACKGROUND Interferons have been reported to significantly contribute to tumor suppression via both induction of p53 gene expression and inhibition of angiogenesis. OBJECTIVE The assessment of treatment toxicity and antitumoral effectiveness of continuous IV administration of interferon-beta based on an overall evaluation of laboratory, radiographic, and clinical parameters observed during the trial. METHODS The authors treated patients with advanced malignant melanoma with continuous IV infusions of 1 x 10(6) IU interferon-beta daily ( approximately 0.6 x 10(6) IU interferon-beta/m2 daily). RESULTS Continuous IV administration of interferon-beta had no significant effect on overall patient…

MaleOncologymedicine.medical_specialtySkin NeoplasmsAngiogenesisAntineoplastic AgentsDrug Administration ScheduleInterferonInternal medicinemedicineHumansIn patientNeoplasm MetastasisInfusions IntravenousMelanomaAgedInterferon betabusiness.industryMelanomaInterferon-betaGeneral MedicineMiddle Agedmedicine.diseaseCombined Modality TherapyDiscontinuationSurgeryTreatment OutcomeToxicityFemalebusinessmedicine.drugSKINmed
researchProduct

Delineating margins of lentigo maligna using a hyperspectral imaging system

2014

Lentigo maligna (LM) is an in situ form of melanoma which can progress into invasive lentigo maligna melanoma (LMM). Variations in the pigmentation and thus visibility of the tumour make assessment of lesion borders challenging. We tested hyperspectral imaging system (HIS) in in vivo preoperative delineation of LM and LMM margins. We compared lesion margins delineated by HIS with those estimated clinically, and confirmed histologically. A total of 14 LMs and 5 LMMs in 19 patients were included. HIS analysis matched the histopathological analysis in 18/19 (94.7%) cases while in 1/19 (5.3%) cases HIS showed lesion extension not confirmed by histopathology (false positives). Compared to clinic…

MalePathologySkin NeoplasmsHyperspectral imaginghyperspectral imagingSURGERYLentigo malignaHutchinson's Melanotic Freckle030207 dermatology & venereal diseases0302 clinical medicinelentigo maligna melanomaImage Processing Computer-AssistedPhotographyMelanomaAged 80 and overtumour margin assessmentMelanomaBiopsy NeedleHyperspectral imagingGeneral MedicineImmunohistochemistry3. Good healthTumour margin assessment030220 oncology & carcinogenesisDisease ProgressionFemaleRadiologylentigo malignamedicine.symptomDiagnostic Imagingmedicine.medical_specialtyDermoscopyDermatologyLentigo malignaSensitivity and SpecificitySampling StudiesDiagnosis DifferentialLesion03 medical and health sciencesMANAGEMENTmedicineHumansCONFOCAL MICROSCOPYALGORITHMLentigo maligna melanomaAgedSKIN-CANCERbusiness.industryLentigo maligna melanomaCAREmedicine.disease3121 General medicine internal medicine and other clinical medicineHistopathologybusiness
researchProduct

Erythrophagocytic tumour cells in melanoma and squamous cell carcinoma of the skin

1997

Aims: Erythrophagocytosis is a characteristic feature of tumour cells in malignant histiocytosis, some leukaemias, lymphomas, and also reactive histiocytes in the haemophagocytic syndrome associated with a variety of infections and neoplasms. It has also been found exceptionally in metastatic malignant epithelial cells in bone marrow and lymph nodes. We present two cases, a cutaneous malignant melanoma and an acantholytic squamous cell carcinoma, in which erythrophagocytosis by tumour cells was demonstrable by both light and electron microscopy. Methods and results: The melanocytic and squamous nature of these cells was supported by the immunohistochemical detection of HMB45, S100, and NKI-…

MalePathologymedicine.medical_specialtyErythrocytesSkin NeoplasmsHistologyMalignant histiocytosisBiologyPathology and Forensic MedicineCytokeratinPhagocytosisAntigens NeoplasmBiomarkers TumormedicineHumansMelanomaHistiocyteAgedAged 80 and overMelanomaMucin-1General Medicinemedicine.diseaseImmunohistochemistryErythrophagocytosisNeoplasm ProteinsMicroscopy ElectronHaematopoiesismedicine.anatomical_structureEpidermoid carcinomaCarcinoma Squamous CellBone marrowMelanoma-Specific AntigensHistopathology
researchProduct

Diagnostic value of CD34 immunostaining in desmoplastic trichilemmoma.

1998

Desmoplastic trichilemmoma (DT) is a variant of trichilemmoma, characterized by a central prominent desmoplastic component which may simulate invasive carcinoma. We have studied the morphologic and immunohistochemical features of seven cases of DT. Immunohistochemistry was performed on paraffin sections using monoclonal antibodies to CD34 (QBEND/10), vimentin and GCDFP-15. CD34 was also tested in seven cases of basal cell carcinoma (BCC), three with outer root sheath differentiation and four with morphea-form features, and five squamous cell carcinomas. Histologically, features of conventional trichilemmoma were seen at the periphery of the seven lesions. In contrast, at the center, the epi…

MalePathologymedicine.medical_specialtyHistologySkin NeoplasmsCD34VimentinAntigens CD34DermatologyBiologyOuter root sheathPathology and Forensic MedicineDiagnosis DifferentialPredictive Value of TestsmedicineCarcinomaBiomarkers TumorHumansVimentinBasal cell carcinomaApolipoproteins DAgedGlycoproteinsNeoplasms Basal CellSkinTrichilemmomaHistocytochemistryMembrane Transport ProteinsMiddle Agedmedicine.diseaseImmunohistochemistryApolipoproteinsCarcinoma Basal Cellbiology.proteinCarcinoma Squamous CellImmunohistochemistryFemaleCarrier ProteinsImmunostainingJournal of cutaneous pathology
researchProduct

Slow-growing angiomatous lesions on the limbs.

2014

MalePathologymedicine.medical_specialtyLegSkin Neoplasmsbusiness.industryMycobacterium Infections NontuberculousGeneral MedicineDiagnosis DifferentialNeoplasms Multiple PrimaryAngiomatosis BacillaryArmMedicineHumansbusinessSlow GrowingSarcoma KaposiAgedCleveland Clinic journal of medicine
researchProduct

Cutaneous complications of Anderson-Fabry disease.

2013

Anderson-Fabry disease is an X-linked lysosomal storage disorder caused by a defect in the -galactosidase A gene, which leads to the deficiency of the hydrolytic enzyme -galactosidase A. The consequent inability to catabolize glycosphingolipids causes progressive accumulation of globotriaosylceramide in the vascular endothelium throughout the body. Fatalities in the classical phenotype may usually occur as a consequence of cerebral, cardiac or renal disease. Dermatological manifestations are a relevant feature of Fabry disease and include angiokeratomas, telangiectasiae, lymphedema, anhidrosis or hypohidrosis and pseudo-acromegalic facial appearance. The actual causal treatment for Fabry …

MalePathologymedicine.medical_specialtySkin NeoplasmsGlobotriaosylceramideDiseaseDiagnosis Differentialchemistry.chemical_compoundDrug DiscoverymedicineHumansAge FactorEnzyme Replacement TherapySkin NeoplasmAnhidrosisSkinPharmacologySex CharacteristicsVascular diseasebusiness.industryAge FactorsEnzyme replacement therapySex Characteristicmedicine.diseaseFabry diseaseAngiokeratomaLymphedemachemistryalpha-GalactosidaseFabry DiseaseFemalemedicine.symptombusinessHumanAngiokeratomaCurrent pharmaceutical design
researchProduct

Biphasic dermatofibrosarcoma protuberans with a labyrinthine plexiform high‐grade fibrosarcomatous transformation

2013

Several variants of dermatofibrosarcoma protuberans, a low-grade superficial sarcoma, are well recognized. The most prognostically important is the fibrosarcomatous variant. We report a case of biphasic dermatofibrosarcoma protuberans in which the high-grade component exhibited a previously undescribed plexiform pattern. A clinicopathological study complemented with immunohistochemical, ultrastructural, reverse transcription polymerase chain reaction and fluorescence in situ hybridization analyses of this unique case. Histopathologically, a conventional low-grade dermatofibrosarcoma protuberans was admixed with intratumoral high-grade areas showing a striking labyrinthine plexiform pattern …

MalePathologymedicine.medical_specialtySkin NeoplasmsHistologyOncogene Proteins FusionFibrosarcomaCD34DermatologyBiologyPathology and Forensic MedicinemedicineDermatofibrosarcoma protuberansHumansIn Situ Hybridization FluorescencePDGFBmedicine.diagnostic_testDermatofibrosarcomaMiddle AgedPrognosismedicine.diseaseImmunohistochemistryCell Transformation NeoplasticCOL1A1/PDGFB Fusion GeneImmunohistochemistrySarcomaImmunostainingFluorescence in situ hybridizationJournal of Cutaneous Pathology
researchProduct